Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 10:00 am Sale | 2022-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 0 0.000% | -4,695,020 (Position Closed) | Filing History |
| 2022-11-10 4:06 pm Sale | 2022-10-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | MORGAN STANLEY MS | 384,245 0.800% | -3,686,147 (-90.56%) | Filing History |
| 2022-02-14 12:39 pm Sale | 2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | PFM Health Sciences LP | 1,088,566 2.300% | -1,725,797 (-61.32%) | Filing History |
| 2022-02-11 4:08 pm Purchase | 2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 4,695,020 9.910% | 2,159,519 (+85.17%) | Filing History |
| 2022-02-09 3:16 pm Sale | 2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | The Vanguard Group | 3,381,368 7.140% | -835,703 (-19.82%) | Filing History |
| 2022-02-09 1:28 pm Purchase | 2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | MORGAN STANLEY MS | 4,070,392 8.600% | 4,070,392 (New Position) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | BlackRock Inc. BLK | 3,386,015 7.100% | -506,226 (-13.01%) | Filing History |
| 2021-08-16 5:06 pm Purchase | 2021-08-04 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 2,535,501 5.370% | 2,041,285 (+413.03%) | Filing History |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | PFM Health Sciences LP | 2,814,363 6.000% | 382,864 (+15.75%) | Filing History |
| 2021-02-10 10:30 am Sale | 2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | The Vanguard Group | 4,217,071 9.010% | -20,420 (-0.48%) | Filing History |
| 2021-02-09 3:14 pm Sale | 2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | HARTFORD MUTUAL FUNDS INC | 0 0.000% | -2,597,265 (Position Closed) | Filing History |
| 2021-02-05 07:51 am Purchase | 2020-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | BlackRock Inc. BLK | 3,892,241 8.300% | 410,029 (+11.77%) | Filing History |
| 2020-07-09 10:10 am Sale | 2020-06-30 | 13G | Aerie Pharmaceuticals, Inc. AERI | Wellington Management Group LLP | 1,194,841 2.570% | -3,096,359 (-72.16%) | Filing History |
| 2020-06-30 4:35 pm Sale | 2020-06-30 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 494,216 1.060% | -2,037,931 (-80.48%) | Filing History |
| 2020-06-12 3:09 pm Sale | 2020-03-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | Foresite Capital Fund II L.P. | 837,907 1.800% | -4,686,684 (-84.83%) | Filing History |
| 2020-06-09 10:04 am Sale | 2020-05-29 | 13G | Aerie Pharmaceuticals, Inc. AERI | Wellington Management Group LLP | 4,291,200 9.230% | -2,451,497 (-36.36%) | Filing History |
| 2020-03-24 4:35 pm Purchase | 2020-03-13 | 13G | Aerie Pharmaceuticals, Inc. AERI | James E. Flynn | 2,532,147 5.450% | 759,892 (+42.88%) | Filing History |
| 2020-02-14 4:05 pm Sale | 2019-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | PFM Health Sciences LP | 2,431,499 5.200% | -244,400 (-9.13%) | Filing History |
| 2020-02-14 10:20 am Sale | 2019-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | HARTFORD MUTUAL FUNDS INC | 2,597,265 5.610% | -100,640 (-3.73%) | Filing History |
| 2020-02-13 9:21 pm Purchase | 2019-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | Foresite Capital Fund II L.P. | 5,524,591 11.900% | 390,900 (+7.61%) | Filing History |